Skip to main content
CPRX logo

Catalyst Pharmaceuticals, Inc.

CPRXNASDAQHealthcareBiotechnology

$31.49Today:- (-)1Y +51.91%

As of Jul 21, 2026 close

Market cap
$4.00B
P/E (TTM)
18.06
Forward P/E
-
Dividend yield
-
52-week range
$21.52$32.56
Volume (live)
-
Avg. volume (3M)
-

CPRX was delisted on Oct 24, 2026. Data shown is historical and no longer updated.

Catalyst Pharmaceuticals (CPRX) Stock Price & Financial Analysis

Catalyst Pharmaceuticals Stock Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Price & Trading Activity
Day's Range$31.49 - $31.49
52-Week High$32.56
52-Week Low$21.52
Open$31.49
Earnings & Profitability
Revenue (TTM)596.96M
Net Income (TTM)221.32M
Free Cash Flow (TTM)208.13M
EPS (TTM)$1.74
Profit Margin37.08%
Operating Margin44.83%
Return on Equity (ROE)21.85%
Debt to Equity0.00
Dividend Information
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%
Size & Valuation
Market Cap4.00B
Shares Outstanding126.90M
P/E Ratio (TTM)18.06
Price to Sales (P/S)6.69
Price to Book (P/B)3.95
EV/EBITDA10.23
Technical Indicators
50-Day MA$31.35
200-Day MA$25.64
1-Year Change+51.91%

Source: Market prices and company fundamentals. Data as of Jul 21, 2026. Data sources and methodology

Compare CPRX with other stocks

Catalyst Pharmaceuticals at a Glance

As of the Jul 21, 2026 close, Catalyst Pharmaceuticals (CPRX) has a market capitalization of $4.00B. The stock trades at 18.1× trailing earnings and 6.7× sales. Over the trailing twelve months it earned $221.32M on revenue of $596.96M (a 37.1% profit margin) and generated $208.13M of free cash flow. Revenue grew 11.7% year over year.

As of its latest reported balance sheet, it holds $755.86M in cash and securities against $2.68M of debt, a net cash position of $753.18M.

Catalyst Pharmaceuticals does not currently pay a dividend.

The share price is up 51.9% over the past year. At $31.49 (the Jul 21, 2026 close) it sits near the top of its 52-week range of $21.52 to $32.56, above its 200-day moving average of $25.64.

ETFs Holding CPRX

Largest funds holding CPRX, by assets

As of Oct 4, 2026, Catalyst Pharmaceuticals (CPRX) is among the top 50 holdings of 2 US ETFs.

Largest ETFs holding CPRX by assets
ETFNameWeightAUMExpense Ratio
ARBAltShares Merger Arbitrage ETF1.85%$103.15M0.76%
EVNTAltShares Event-Driven ETF2.51%$13.12M1.33%

Source: ETF top holdings as reported by fund issuers (largest ~50 positions per fund). Data as of Oct 4, 2026. Data sources and methodology

Find more ETFs in the ETF screener

Frequently Asked Questions About Catalyst Pharmaceuticals

What is the current stock price for CPRX?

As of the Jul 21, 2026 close, CPRX stock trades at $31.49. The 52-week range is $21.52–$32.56, with a day range of $31.49–$31.49.

What is the P/E ratio for CPRX?

As of the Jul 21, 2026 close, Catalyst Pharmaceuticals's trailing twelve-month (TTM) P/E ratio is 18.1, meaning investors pay $18.1 for every $1 of annual earnings. Catalyst Pharmaceuticals operates in the Healthcare sector.

Does CPRX pay dividends?

Catalyst Pharmaceuticals does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.

What is the market cap of CPRX?

As of the Jul 21, 2026 close, Catalyst Pharmaceuticals's market capitalization is $4.00B, classifying it as a mid-cap company. Catalyst Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.